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Abstract  
Aristotelia  chilensis is a native berry from southern Chile with a high content of anthocyanins, compounds that exhibit antioxidant and anti-inflammatory 
properties. In the present study, we evaluated the effects of A. chilensis berry juice on cyclooxygenase (COX)-2 expression, intracellular signaling pathways, 
and cell viability in colon cancer cells. The treatment of Caco-2 cells with A. chilensis diluted juice for 24 h reduced the protein and mRNA expression of 
COX-2, as well as the TNF--induced NF-B luciferase activity and NFAT activation. In contrast, 4 h after administration, A. chilensis transiently reduced 
the cytoplasmic IB levels and increased ERK1/2 and Akt phosphorylation as well as c-fos expression. At concentrations that reduced COX-2 expression, 
A. chilensis did not affected Caco-2 cell viability. Our results suggest a potential anti-carcinogenic and anti-inflammatory effect of A. chilensis. 
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Resumen 
Aristotelia  chilensis es un berrie originario del sur de Chile, que posee un alto contenido de antocianinas, compuestos con propiedades antioxidantes y anti-
inflamatorias. En este estudio, se evaluó los efectos de un concentrado de A. chilensis sobre expresión de ciclooxigenasa (COX)-2, vías de señalización y 
viabilidad en células de cáncer de colon. El tratamiento de células Caco-2 con A. chilensis por 24 h redujo la expresión de la proteína y mRNA de COX-2, y 
disminuyó la actividad luciferasa regulada por NF-B o NFAT. El tratamiento de células Caco-2 por 4 h con A. chilensis redujo transitoriamente los niveles 
citoplasmáticos de IB, aumentó la fosforilación de ERK1/2 y Akt y la expresión de c-fos. A. chilensis no afectó la viabilidad celular, a concentraciones que 
redujo la expresión de COX-2. Los resultados sugieren un potencial efecto anticancerígeno y antiinflamatorio de A. chilensis. 
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INTRODUCTION 
Aristotelia chilensis (Maqui) is an endemic Chilean 
berry. It is a dioecious plant that belongs to the family 
Elaeocarpaceae that grows in slightly acidic, 
moderately fertile and well-drained soils. It produces 
small edible purple/black berries, about 6 mm in 
diameter, which are eaten fresh or used for juice, jams 
or wine-making. The leaves and fruits are astringent 
and  have been used in Chilean folk medicine as anti-
diarrheic, anti-inflammatory agents, anti-hemorrhagic 
and febrifuges (Hoffmann et al., 1992). The red color 
of the aqueous extract of its fruit is due to the presence 
of anthocyanin pigments.  
The average total anthocyanin content is 137.6 
± 0.4 mg/100 g of fresh fruit, with 73% of delphinidin 
derivatives and 37% derived from cyanidin. The main 
pigments identified are 3-glucosides, 3,5-diglucosides, 
3-sambubiosides and 3- sambubioside-5-glucosides of 
delphinidin and cyanidin, with delphinidin 3- 
sambubioside-5-glucoside (34% of total anthocyanins) 
as the main anthocyanin (Escribano-Bailon et al., 
2006). The presence of highly polar and water-soluble 
polyglycosylated derivatives in A. chilensis illustrates 
that this berry is attractive for extraction and for the 
potential use in the production of food colorants, as 
well as for pharmacological uses. Concentrated juice 
of A. chilensis has a high content of phenolic 
compounds with antioxidant capacity, which protect 
both LDL from oxidation and endothelial cells from 
intracellular oxidative stress, suggesting that A. 
chilensis could have antiatherogenic properties 
(Miranda-Rottmann et al., 2002). 
Anthocyanins are known to be powerful 
antioxidants, and have been demonstrated to inhibit 
COX-2 expression, an enzyme up-regulated in colon 
cancer.  Anthocyanins inhibit COX-2 and PGE2 
production through a nuclear factor-kappaB (NF-B)-
dependent pathway as well as regulate the PI3 
kinase/Akt pathway activated by UVB in the human 
keratinocyte cell line HaCaT (Tsoyi et al., 2008). 
Delphinidin inhibits COX-2 expression in different 
cells, such as JB6 promotion-sensitive mouse skin 
epidermal (JB6 P+) cells (Kang et al., 2008) and TPA-
stimulated HT-29 cells (Kim et al., 2008). Cyanidin 
reduced COX-2 expression and PGE2 production in 
human prostate cancer cells (Munoz-Espada et al., 
2006) and in TPA-stimulated HT-29 cells (Kim et al., 
2008). Also, cyanidin-3-O-beta-glucoside inhibits 
iNOS and COX-2 expression in THP-1 macrophages 
(Wang et al., 2008). On the other hand, the juice from 
different small edible berries has been evaluated for its 
effects on different cancer cell lines, revealing an 
inhibition of  cell proliferation, activation of the 
nuclear transcription factor NF-B, and TNF-induced 
activation of COX-2 expression (Boivin et al., 2007). 
All these antecedents suggest a potential anti-
inflammatory and anti-carcinogenic effect of A. 
chilensis. In this study, we evaluated the in vitro effect 
of A. chilensis on the colon cancer cell line Caco-2, 
which exhibits a high level of COX-2 expression. We 
assessed the effect of A. chilensis on mRNA and 
protein COX-2 levels and the signaling pathways 
involved in COX-2 expression such as NF-B, NFAT, 
c-fos, ERK1/2 MAPK and Akt in Caco-2 cells. Our 
results showed two different effects of A. chilensis: the 
short-term treatment caused a transient stimulation of 
IBα, c-fos, Akt and ERK/1/2, whereas at long-term 
treatment a strong reduction of COX-2 was detected.  
 
MATERIAL AND METHODS 
A. chilensis berry juice was kindly provided by Herbal 
Powers (Bradenton, FL, USA). The content of 
anthocyanins was determined by HPLC. Concentrated 
juice A. chilensis was diluted in culture medium before 
each experiment and a concentration equivalent to 50 
ng/ml anthocyanins was used in all experiments. 
 
HPLC 
Concentrated juice from A. chilensis was analyzed 
according to the analytical method described by 
Escribano-Bailon (Escribano-Bailon et al., 2006).  
 
Cell Culture 
The cell line of colorectal adenocarcinoma Caco-2 
(ATCC, Manassas, VA, USA) was grown in Eagle's 
Minimum Essential Medium medium (Gibco, Grand 
Island, NY, USA) supplemented with 10% FBS. The 
cells were maintained at 37°C in a humidified 
atmosphere of 5% CO2. 
 
Immunoblotting. Caco-2 cells were incubated with A. 
chilensis for different times and total proteins extracts 
or cytosolic extracts were prepared. Afterwards, 50 g 
of proteins were resolved in 12% SDS/PAGE, 
transferred to a nitrocellulose membrane. The 
immunoblotting was carried out using antibodies 
against COX-2 (Cayman Chemical, Ann Arbor, MI, 
USA), phospho-ERK1/2, phospho-Akt (ser473), total 
Akt, c-fos, IB (Cell Signaling Technology, Boston, 
MA, USA), total ERK1/2 (Santa Cruz Biotechnology, 
California, CA, USA), according to the recommended 
manufacturer’s dilution (Hidalgo et al., 2004). Blots 
were developed with an enhanced chemiluminescence 
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system. The phosphorylated proteins were normalized 
against the nonphosphorylated proteins or COX-2 and 
c-fos against beta-actin (Sigma-Aldrich, St Louis, MO, 
USA) or alpha-tubulin (Molecular Probes, Eugene, 
OR, USA). The ImageJ software from NIH was 
employed to analyze the blots.  
 
Real-time PCR 
Caco-2 cells were incubated with A. chilensis or 
solvent for 24 h. Total RNA was isolated with the 
RNAEasy Kit (Qiagen, Hilden, Germany) and 1 g 
was used for cDNA synthesis with oligo dT primers 
and MMLV reverse transcriptase (Promega, Madison, 
WI, USA). Real-time PCR was performed using 2 l 
of cDNA, master mix SYBRGreen (Stratagene, La 
Jolla, CA, USA) and the following primer: COX-2 
sense 5’– TGC ATT CTT TGC CCA GCA CT – 3’ 
and antisense 5’ – AAA GGC GCA GTT TAC GCT 
GT – 3’; GAPDH sense 5’– GGC GTG AAC CAC 
GAG AAG TAT AA – 3’ and antisense 5’– CCC TCC 
ACG ATG CCA AAG T – 3’. 
 
Luciferase activity 
Caco-2 cells were transfected with 1 g of pGL3-NF-
kB plasmid or pNFAT-luc and 0.5 g of pRL-TK 
plasmid as a control, in FuGene 6 reagent (Roche 
Diagnostic Corp., Indianapolis, IN, USA) for 24 h, 
according to the manufacturer’s instructions. The cells 
were treated with A. chilensis for 30 min, and then 
stimulated with 10 ng/ml TNF-, 100 ng/ml PMA/ 0.5 
M Ionomycin or solvent for 16 h. The cellular 
extracts were obtained and the luciferase activity was 
measured with the Dual-Luciferase Reporter Assay 
System (Promega, Madison, WI, USA) in a 
luminometer (Luminoskan, Thermo). The luciferase 
activity was expressed as the ratio of RLU pGL-NF-
kB/pRL-TK or pNFAT/pRL.  
 
Cell viability - MTT assay 
Caco-2 cells were incubated with different 
concentrations of A. chilensis, solvent or butyrate (10 
mM) for 24, 48, 72 or 96 h. Then, the mitochondrial 
activity was measured by the modified 3-[4,5-
dimethylthiazol 2-yl]-2,5 diphenyltetrazolium bromide 
(MTT) assay (Mosmann, 1983). This involves 
determining the mitochondrial dehydrogenase activity 
in intact cells by incubation for 4 h at 37° C with MTT 
(10 μl of 5 mg/ml MTT solution per well). The 
reaction was stopped by addition of cell lysis buffer 
(50% dimethylformamide and 20% SDS, pH 7.4). ΔA 
values at 550–650 nm were determined the following 
day using an microtiter plate reader (Tecan). The 
results are expressed as a percentage of control. 
 
Flow cytometry 
Caco-2 cells were incubated with the diluted juice of 
A. chilensis, solvent or 10 mM butyrate for 24 h. Then, 
the cells were stained with Annexin V-FITC and 
propidium iodide (BD) according to the instruction of 
the manufacturer. The cells were analyzed on a flow 
cytometer (FACSCanto II, BD). 
 
Statistical analysis 
The results were expressed as the ratio or fold of 
control increase and depicted as the mean ± s.e. An 
ANOVA was performed and a Dunnet’s multiple 
comparison test was applied using GRAPH PAD V 
2.0. A level of significance of 5% was used. 
 
RESULTS 
Identification of anthocyanin in A. chilensis 
concentrate juice 
The HPLC analysis showed that the concentrate juice 
of  A. chilensis possesses 0.5423% anthocyanins (w/w)  
/ 100 g dry fruit and the following specific 
anthocyanins species were detected: 0.1359% (w/w) 
delphinidin 3-O-sambubioside-5-o-glucoside,  0.1112 
% (w/w) delphinidin 3,5-o-diglucoside, 0.1297% 
(w/w) cyanidin 3-O-sambubioside-5-o-glucoside, 
0.0516% (w/w) delphinidin 3-O-sambubioside, 
0.0735% (w/w) delphinidin 3-o-glucoside, 0.0271% 
(w/w) cyanidin 3-O-sambubioside and 0.0115% (w/w) 
cyanidin 3-o-glucoside.  
 
A. chilensis reduces COX-2 expression in Caco-2 
cells 
It has been well established that COX-2 is highly 
expressed in human colon cancer and Caco-2 cells 
(Accioly et al., 2008; Eberhart et al., 1994; Kargman 
et al., 1995; Sano et al., 1995). In this study, Caco-2 
cells were incubated with A. chilensis for 0, 24, 48 or 
72 h and the COX-2 protein was analyzed by 
immunoblot. The treatment of Caco-2 cells with A. 
chilensis showed a 50% of reduction in the COX-2 
protein level from 24 h of incubation compared to the 
control (Figure 1A). The mRNA expression of COX-2 
at 24 h of treatment with A. chilensis was analyzed by 
real-time PCR, and similar to protein expression, a 
reduction of 50% with respect to the control in the 
cells treated with A. chilensis was observed (Figure 
1B). These results indicate that A. chilensis interferes 
with the basal COX-2 expression at the protein and 
mRNA levels in Caco-2 cells. 
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Figure 1 
  
 
 
Effect of A. chilensis on COX-2 expression. Caco-2 cells were incubated with A. chilensis (A.ch.) for 0, 24, 48 or 
72 h followed by isolation of total proteins or RNA. (A) The COX-2 protein level was analyzed by immunoblotting 
using an antibody against COX-2, and the blot was stripped and re-probed with anti--actin antibody. (B) The 
mRNA expression of COX-2 at 24 h of treatment with A. chilensis was assessed by reverse transcription and real-
time PCR. The graphs show the mean ± S.E. from three independent experiments. *p < 0.05 compared to the 
control. 
 
 
NF-B and NFAT activation are reduced by A. 
chilensis 
NF-B is a transcription factor activated by pro-
inflammatory mediators, which regulates expression of 
COX-2 (Duque et al., 2006). Caco-2 cells were 
transfected with the reporter plasmid pNF-B-luc and 
pRL-TK, treated with A. chilensis or vehicle and 
incubated with TNF- or vehicle for 16 h. The 
treatment with A. chilensis itself did not modify the 
NF-B-luc activity compared to the control (Figure 
2A). Additionally, an increase in the luciferase activity 
induced by TNF- was observed, and the pre-
treatment of the cells with A. chilensis for 30 min and 
followed by stimulation with TNF- resulted in an  
 
 
 
 
 
inhibition of TNF--induced activation of NF-B. 
These results indicate that A. chilensis exerts the 
inhibitory effects on NF-B only when this pathway 
was activated by a pro-inflammatory cytokine. 
In colon carcinoma cells, the nuclear factor of 
activated T cells (NFAT) has important implications in 
the regulation of Cox-2 expression (Corral et al., 2007; 
Duque et al., 2005). We assessed the effect of A. 
chilensis on NFAT activation in Caco-2 cells 
transfected with the reporter plasmid pNFAT-luc. 
PMA/Ionomycin induced the NFAT activation and the 
pre-treatment with A. chilensis statistically decreased 
this effect, suggesting the participation of NFAT in 
Cox-2 expression (Fig 2B).  
 
 
 
 
 
 
Ojeda et al Effect of A. chilensis on colon cancer cells 
 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/547 
 
Figure 2
 
Effect of A. chilensis on NF-B and NFAT activation. Caco-2 cells were transiently transfected with the pGL3-
NF-B (A) or pNFAT (B) and pRL-TK plasmids for 24 h, treated with 50 ng/ml A. chilensis or vehicle for 30 min, 
then TNF-, PMA/Io or solvent was added for 16 h. Luciferase activity was measured in a luminometer. Each bar 
represents mean ± S.E., n=3, * p<0.05 compared with TNF- in (A) or PMA/Io in (B). 
 
 
 
A. chilensis induces IB degradation, c-fos 
expression, ERK1/2 and Akt phosphorylation 
We studied the effect of A. chilensis on NF-B and on 
c-fos, a component of the AP-1 transcription factor. A. 
chilensis was incubated for different lengths of time 
(0, 0.5, 1, 2, 4, 8 or 24 h) and the IB level and c-fos 
were evaluated by immunoblot. We assessed the 
activation of the NF-B pathway by IB 
degradation, an inhibitory protein of the NF-B 
traslocation into the nucleus, which is transcriptionally 
regulated by the NF-B pathway. The immunoblotting 
of IB showed that A. chilensis transiently reduced 
the levels of this protein between 2 and 4 h of 
incubation, suggesting activation of NF-B. As a 
positive control, the stimulation with TNF- was used 
and a reduction in the level of IB was evident  
 
 
 
 
(Figure 3A). On the other hand, Caco-2 cells did not 
express c-fos in the absence of stimuli, but when the 
cells were treated with A. chilensis, an increase in the 
c-fos expression between 4 and 24 h of treatment was 
observed (Figure 3B). 
Because the transcription factors AP-1 and 
NF-B are controlled by ERK1/2 MAPK and Akt 
pathway, Caco-2 cells were incubated for different 
times (0 to 240 min) with A. chilensis, then ERK1/2 
and Akt phosphorylation was analyzed by 
immunoblot. At time 0, a slight phosphorylation of 
ERK1/2 was observed, however, the treatment for 2 
and 4 h with A. chilensis showed an increase in the 
ERK1/2 phosphorylation, with a maximum effect at 4 
h (Figure 3C). On the other hand, A. chilensis induced 
the Akt phosphorylation between 30 and 120 min, 
with the maximum intensity at 60 min (Figure 3D). 
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Figure 3 
 
 
 
Effect of A. chilensis on IB degradation, c-fos expression and ERK1/2 and Akt phosphorylation. Caco-2 
cells were incubated with 50 ng/ml A. chilensis for different times and cytosolic protein extracts were prepared and 
analyzed by immunoblotting to IB detection (A) or total proteins were obtained and used for analysis of c-fos 
(B), phosphorylation of ERK1/2 (C) and Akt (D) by immunoblotting. The blots were stripped and re-probed with 
-tubulin, -actin or the nonphosphorylated proteins, as a charge control. Picture representative of three 
independent experiments. 
 
Effect of A. chilensis on cell viability in Caco-2 cells 
The effect of A. chilensis on cell viability was studied 
by Annexin V-propidium iodide stain and MTT assay. 
Caco2-cells were treated with A. chilensis for 24 h and 
apoptosis was assessed by staining of Annexin V-
FITC and propidium iodide. Figure 4 (A-C) shows 
that, at 24 h of treatment, A. chilensis did not induce 
early apoptosis or death of Caco-2 cells (butyrate it 
was used as a dead control). The effect of A. chilensis 
on viability of Caco-2 cells at different times (24-96 h) 
was studied by MTT assay. Caco-2 cells treated with 
A. chilensis did not show changes in viability 
compared to the control at anytime (Figure 4D). 
 
DISCUSSION 
The anticancer effects of berries have been mainly 
attributed to their antioxidant and anti-inflammatory 
activities. Phenolic compounds, such as anthocyanins, 
present in different berries show antioxidant activity 
comparable to commercial antioxidants and 
cyclooxygenase inhibitory activity (Seeram et al., 
2001). In our study, we demonstrated for first time that 
berry juice from A. chilensis reduced the basal 
expression of COX-2 mRNA and protein in the 
adenocarcinoma cell line Caco-2. This could be 
explained by the high content of anthocyanins in the A. 
chilensis juice. Several reports show that anthocyanins 
reduce COX-2 expression (Kang et al., 2008; Kim et 
al., 2008; Munoz-Espada et al., 2006; Tsoyi et al., 
2008). Additionally, the ability of anthocyanidins to 
inhibit COX-2 expression in TPA-stimulated HT-29 
cells (Kim et al., 2008) and in rats fed with 
anthocyanin-rich extracts also has been observed (Lala 
et al., 2006). Moreover, anthocyanin-rich extracts 
reduced colonic aberrant crypt foci in colon cancer in 
rats (Lala et al., 2006). Reports suggest an essential 
role of COX-2 in colon cancer. COX-2 is 
overexpressed in 40% of human adenomas and in 80% 
of adenocarcinomas relative to normal mucosa 
(Eberhart et al., 1994; Kargman et al., 1995; Kutchera 
et al., 1996). The COX-2 inhibition with nonsteroidal 
anti-inflammatory drugs (NSAIDs) has been proposed 
in chemoprevention of cancer (Antonakopoulos et al., 
2007; Cha et al., 2007; Harris, 2009). Several studies 
suggest that either non-selective or selective COX-2 
inhibitors produce significant reduction in the risk of 
colon cancer (Chan et al., 2007; Harris et al., 2008; 
Huls et al., 2003). A different effect of celecoxib, a 
selective COX-2 inhibitor, showed a decrease in 
ICAM-1 and VCAM-1 expression in HT-29 cells, 
affecting the adhesive properties of the cells (Dianzani 
et al., 2008; Gallicchio et al., 2008). It has also been 
described that aspirin and sodium salicylate inhibit 
COX-2 expression stimulated by VEGF in colon 
cancer cells (Shtivelband et al., 2003). The inhibitory 
mechanism of salicylate on COX-2 expression has 
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been described via inhibition of the binding of 
CCAAT/enhancer-binding protein beta to the 
promoter region of COX-2 (Saunders et al., 2001); 
however previous reports showed that salicylate, at 
suprapharmacological concentrations,  acts via 
inhibition of the activity of I(kappa)B kinase-beta 
(Kopp et al., 1994; Yin et al., 1998). 
 
Figure 4 
Effect of A. chilensis on cell viability. Caco-2 cells were incubated with A. chilensis or 10 mM butyrate for 24 h 
and then stained with AnnexinV-FITC and PI, or analyzed by MTT assay. The AnnexinV-FITC and PI signals were 
detected by flow cytometry (A-C) and the formazan crystal produced from MTT was registered in a microplate 
lector (D). Each bar represents the mean ± S.E., n=8. ** p<0.01 vs. control. 
 
We assessed the effect of A. chilensis on NF-
B activation in Caco-2 cells, and observed that A. 
chilensis did not change the basal levels of NF-B-luc 
activity or IB degradation at 24 h of treatment. This 
result and the observations of the effect of A. chilensis 
on the basal COX-2 expression suggest that NF-B 
could play a minor role in the basal COX-2 expression 
in Caco-2 cells. Thus, several potential transcriptional 
regulatory elements in the 5’-flanking region of the 
COX-2 gene have been identified, including a 
Ojeda et al Effect of A. chilensis on colon cancer cells 
 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/550 
 
peroxisome proliferator response element (PPRE), two 
cyclic AMP response elements (CRE), a sterol 
response element (SRE), two NF-B sites, an SP1 site, 
a CAAT enhancer binding protein (C/EBP) motif, two 
AP-2 sites, an E-box, TATA box and NFAT sites 
(Corral et al., 2007; Duque et al., 2005; Kang et al., 
2007). We observed that NFAT activation induced 
with PMA/Ionomycin was reduced by A. chilensis in 
Caco-2 cells. Moreover, we did not discard an 
inhibitory effect of A. chilensis on the NF-B 
pathway. We showed that A. chilensis reduced the 
TNF--induced NF-B-luc activity, indicating that the 
NF-B activation by pro-inflammatory cytokines can 
be reduced by A. chilensis. A previous report showed 
that juice from different berries significantly inhibited 
the TNF--induced activation NF-B and COX-2 
expression in cancer cell lines of stomach, prostate, 
intestine and breast (Boivin et al., 2007). Surprisingly, 
A. chilensis, at short time points, induced IB 
degradation, however this effect was transient and 
returned to the basal level at 24 h.  
NF-B activation is regulated through 
intracellular signaling pathways such as PI3K/Akt and 
MAPK cascades (Kyriakis et al., 2001). We observed 
that A. chilensis transiently increased Akt and ERK1/2 
phosphorylation after 60 min and 240 min of 
incubation, respectively. The effect of A. chilensis on 
Akt phosphorylation also displayed a direct 
relationship with increased IB degradation and p65 
NF-B nuclear localization at 4 h of treatment, 
because it has been extensively demonstrated that the 
PI3K/Akt pathway can regulate NF-B activation 
(Kok et al., 2009). It has also been proposed that the 
PI3K pathway regulates COX-2 expression. The use of 
the PI3K inhibitors wortmannin and LY294002 up-
regulated the COX-2 expression in HT-29 and Caco-2 
cells, and the activation of PI3K with IL-4 and IL-13 
down-regulated COX-2 expression, which 
demonstrate that PI3K negatively regulates COX-2 
expression in these cells (Weaver et al., 2001). To 
assess a role of PI3K in the effect of A. chilensis on 
COX-2 expression, Caco-2 cells were pre-incubated 
with the LY294002 inhibitor and then stimulated with 
A. chilensis for 24 h, however no differences between 
the treatments with A. chilensis or LY294002 plus A. 
chilensis were observed (data not shown). A known 
target downstream of the ERK cascade is the 
immediate early gene c-fos, a component of the 
transcription factor AP-1, which is expressed and 
activated via MAPK (Buzzi et al., 2009; Kyriakis et 
al., 2001). We showed that A. chilensis increased c-fos 
expression from 4 h of treatment, however the role of 
the increase of c-fos expression induced with A. 
chilensis on Caco-2 cells remain to be studied. On the 
other hand, ERK1/2 MAPK it has been linked to 
Caco-2 cell proliferation (Buzzi et al., 2009), therefore 
we analyzed if the increase in ERK1/2 
phosphorylation could be correlated to changes in the 
cell cycle, however, we did not observe changes by 
effect of A. chilensis (data not shown).  
In addition, the treatment with A. chilensis at 
concentrations that reduced COX-2 expression 
(equivalent to 50 ng/ml anthocyanin) did not modified 
cell viability of Caco-2 cells. The daily intake of 
anthocyanins has been estimated to be 12.5 
mg/day/person in the United States (Wu et al., 2006). 
On the contrary, higher concentrations of juice of A. 
chilensis affected the cell viability and induced early 
apoptosis and death in cancer colon cells (data not 
shown).  
 
CONCLUSIONS 
We showed that berry juice from A. chilensis could 
contains anti-inflammatory activity in colon cancer 
cells, through reduction in COX-2 expression. 
Interestingly, A. chilensis showed a rapid and transient 
effect as a cell stimulant. Collectively, these results 
indicate that A. chilensis juice shows diverse and 
distinctive effects in comparison to other berries 
(Seeram, 2008), which could be attributable to its 
composition. 
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